>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>(3-Carboxypropyl)trimethylammonium chloride

(3-Carboxypropyl)trimethylammonium chloride

Catalog No.GC33797

(3-카르복시프로필)트리메틸암모늄 클로라이드는 식이성 붉은 고기의 카르니틴을 먹고 사는 장내 미생물총에 의해 중간 대사산물로 생성되는 혈관병성 물질입니다.

Products are for research use only. Not for human use. We do not sell to patients.

(3-Carboxypropyl)trimethylammonium chloride Chemical Structure

Cas No.: 6249-56-5

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$61.00
재고 있음
100mg
US$56.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(3-Carboxypropyl)trimethylammonium chloride is angiopathic substance produced as an intermediary metabolite by gut microbiota that feed on carnitine in dietary red meat.

(3-Carboxypropyl)trimethylammonium chloride is produced as an intermediary metabolite by gut microbes of L-Carnitine to TMAO[1]. (3-Carboxypropyl)trimethylammonium chloride is implicated in arteriosclerosis and long-term cardiovascular death[2].

[1]. Koeth RA, et al. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab. 2014 Nov 4;20(5):799-812. [2]. Susumu Ogawa, et al. The Dynamics of Carnitine, γ-butyrobetaine and Trimethylamine N-oxide in Diabetics and the Effects of Changes in Renal Function. Ogawa et al., J Nephrol Ren Dis 2017, 1:2

리뷰

Review for (3-Carboxypropyl)trimethylammonium chloride

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (3-Carboxypropyl)trimethylammonium chloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.